Growth factors in subglottic stenosis

Annals of Otology, Rhinology and Laryngology

Volumn 105, Issue 12, 1996, Pages 936-943

  Scioscia, Kenneth A ^a,b   Miller, Frederick ^a   April, Max M ^a   Gruber, Barry L ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

fibrogenic peptide; growth factor; subglottic stenosis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SUBGLOTTIC STENOSIS; TISSUE DISTRIBUTION;

EID: 12644314148     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949610501202     Document Type: Article

References (26)

1. Papsidero MJ, Pashley NRT. Acquired stenosis of the upper airway in neonates. An increasing problem. Ann Otol Rhinol Laryngol 1980;89:512-4.
2. Ratner I, Whitfield J. Acquired subglottic stenosis in the very-low-birth-weight infant. Am J Dis Child 1983;137:40-3.
3. Grundfast KM, Camilon FS Jr, Pransky S, Barber CS, Fink R. Prospective study of subglottic stenosis in intubated neonates. Ann Otol Rhinol Laryngol 1990;99:390-5.
4. Park SS, Streitz JM, RebeizEE, Shapshay SM. Idiopathic subglottic stenosis. Arch Otolaryngol Head Neck Surg 1995;121: 894-7.
5. Sara VR, Hall K, Low H, eds. Growth factors: from genes to clinical application. New York, NY: Raven Press, 1990.
6. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992;90:1-7.
7. Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol 1990;259:L159-L184.
8. Ross R, Raines EW, Bowen-Pope DF. The biology of the platelet-derived growth factor. Cell 1988;46:155-69.
9. Gay S, Trabandt A, Moreland LW, Gay RE. Growth factors, extracellular matrix, and oncogenes in scleroderma. Arthritis Rheum 1992;35:304-10.
10. Pierce GF, MugtoeTA, Senia RM, et al. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med 1988; 167:974-87.
11. Burgess AW. Epidermal growth factor and transforming growth factor alpha. Br Med Bull 1989;45:401-24.
12. Konturek SJ. Epidermal growth factor in protection, repair and healing of gastroduodenal mucosa. J Clin Gastroenterol 1991;13(suppl 1):588-97.
13. Schultz GS, White M, Mitchell R, et al. Epithelial wound healing enhanced by transforming growth factor alpha and vaccinia growth factor. Science 1987;235:350-2.
14. Rifkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989;109:1-6.
15. Roberts AB, Sporn MB. The transforming growth factors-β. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors. Heidelberg, Germany: Springer-Verlag, 1990:419-72. (Handbook of experimental pharmacology; vol95/ 1.)
16. Roberts AB, Sporn MB. The transforming growth factors-β. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors. Heidelberg, Germany: Springer-Verlag, 1990:419-72. (Handbook of experimental pharmacology; vol95/ 1.)
17. Sporn MB, Roberts AB. Transforming growth factor-β: recent progress and new challenges. J Cell Biol 1992;119:1017-21.
18. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of trans-forming growth factor-beta. J Cell Biol 1987;105:1039-45.
19. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990;63:515-21.
20. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-71.
21. Czaja MJ, Weiner FR, Flanders KC, et al. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 1989;108:2477-82.
22. Castilla A, Prieto J, Fausto N. Transforming growth factor β1 and alpha in chronic liver disease. Effects of Interferon alpha therapy. N Engl J Med 1991;324:933-40.
23. Kuzolik M, Hogg A, Lankat Buttgereit B, Krieg T. Colocalization of transforming growth factor-β2 with alpha 1(1) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 1990;86:917-22.
24. Connor TB Jr, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J Clin Invest 1989;83:1661-6.
25. Kaufman LD, Gruber BL, Gomez-Reino JJ, Miller F. Fibrogenic growth factors in the eosinophilia-myalgia syndrome and the toxic oil syndrome. Arch Dermatol 1994;130:41-7.
26. Gay S, Jones RE Jr, Huang G, Gay RE. Immunohistologic demonstration of platelet derived growth factor (PDGF) and sisoncogene expression in scleroderma. J Invest Dermatol 1989;92: 301-3.